Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, epidermolysis bullosa, hereditary disease, hereditary skin disorder, skin disorder, vesiculobullous skin diseaseActive, not recruitingPhase 32025-12-10NCT05464381

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
RHEACELL GmbH & Co. KG3

16 results · Page 1 of 1

Swipe the table sideways for more columns.